Cramer Rosenthal Mcglynn LLC Bio Rad Laboratories, Inc. Transaction History

Cramer Rosenthal Mcglynn LLC

$1.69 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$350.25 - $422.63 $1.15 Million - $1.39 Million	-3,286 Reduced 4.86%	64,289 $23 Million
Q2 2023 Aug 14, 2023	SELL	$359.49 - $486.4 $4.85 Million - $6.57 Million	-13,498 Reduced 16.65%	67,575 $25.6 Million
Q1 2023 May 12, 2023	BUY	$418.69 - $503.0 $858,733 - $1.03 Million	2,051 Added 2.6%	81,073 $38.8 Million
Q4 2022 Feb 13, 2023	BUY	$351.71 - $456.01 $7.03 Million - $9.12 Million	19,996 Added 33.88%	79,022 $33.2 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $5.64 Million - $7.7 Million	13,677 Added 30.16%	59,026 $24.6 Million
Q2 2022 Aug 12, 2022	BUY	$463.67 - $597.16 $7.81 Million - $10.1 Million	16,838 Added 59.06%	45,349 $22.4 Million
Q1 2022 May 16, 2022	SELL	$524.57 - $735.42 $463,719 - $650,111	-884 Reduced 3.01%	28,511 $16.1 Million
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $389,862 - $437,074	-550 Reduced 1.84%	29,395 $22.2 Million
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $426,853 - $535,924	-649 Reduced 2.12%	29,945 $22.3 Million
Q2 2021 Aug 16, 2021	SELL	$576.64 - $649.04 $1.16 Million - $1.31 Million	-2,013 Reduced 6.17%	30,594 $19.7 Million
Q1 2021 May 17, 2021	SELL	$547.01 - $662.35 $10 Million - $12.1 Million	-18,282 Reduced 35.93%	32,607 $18.6 Million
Q4 2020 Feb 16, 2021	SELL	$510.68 - $643.45 $12 Million - $15.1 Million	-23,492 Reduced 31.58%	50,889 $29.7 Million
Q3 2020 Nov 13, 2020	SELL	$454.43 - $535.6 $4.38 Million - $5.17 Million	-9,644 Reduced 11.48%	74,381 $38.3 Million
Q2 2020 Aug 14, 2020	SELL	$334.87 - $493.06 $21.2 Million - $31.2 Million	-63,320 Reduced 42.97%	84,025 $37.9 Million
Q1 2020 May 15, 2020	SELL	$320.01 - $409.07 $2.15 Million - $2.75 Million	-6,733 Reduced 4.37%	147,345 $51.7 Million
Q4 2019 Feb 13, 2020	SELL	$319.73 - $374.2 $4.38 Million - $5.13 Million	-13,707 Reduced 8.17%	154,078 $57 Million
Q3 2019 Nov 13, 2019	SELL	$304.55 - $345.24 $1.89 Million - $2.15 Million	-6,220 Reduced 3.57%	167,785 $55.8 Million
Q2 2019 Aug 13, 2019	SELL	$286.93 - $312.59 $1.55 Million - $1.68 Million	-5,385 Reduced 3.0%	174,005 $54.4 Million
Q1 2019 May 14, 2019	SELL	$224.3 - $317.41 $4.77 Million - $6.75 Million	-21,266 Reduced 10.6%	179,390 $54.8 Million
Q4 2018 Feb 13, 2019	BUY	$220.1 - $309.0 $3.04 Million - $4.26 Million	13,798 Added 7.38%	200,656 $46.6 Million
Q3 2018 Nov 14, 2018	SELL	$289.28 - $326.15 $1.17 Million - $1.32 Million	-4,054 Reduced 2.12%	186,858 $58.5 Million
Q2 2018 Aug 14, 2018	BUY	$244.1 - $303.88 $9.53 Million - $11.9 Million	39,046 Added 25.71%	190,912 $55.1 Million
Q1 2018 May 15, 2018	BUY	$233.97 - $274.11 $10.6 Million - $12.5 Million	45,446 Added 42.7%	151,866 $38 Million
Q4 2017 Feb 14, 2018	SELL	$216.94 - $271.3 $37.1 Million - $46.4 Million	-170,874 Reduced 61.62%	106,420 $25.4 Million
Q3 2017 Nov 14, 2017	SELL	$212.27 - $242.28 $730,208 - $833,443	-3,440 Reduced 1.23%	277,294 $61.6 Million
Q3 2017 Nov 13, 2017	SELL	$212.27 - $242.28 $8.11 Million - $9.26 Million	-38,208 Reduced 11.98%	280,734 $62.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	318,942	318,942 $72.2 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.38B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cramer Rosenthal Mcglynn LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cramer Rosenthal Mcglynn LLC with notifications on news.

Account